SION
NASDAQ
$45.69
Sionna Therapeutics Inc (SION)
Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders, notably Alzheimer's and Parkinson's diseases linked to protein misfolding. The company boasts a robust pipeline supported by proprietary technologies aimed at addressing substantial unmet medical needs within this urgent therapeutic space. Through strategic partnerships and a strong commitment to research and development, Sionna is well-positioned to become a leader in the biopharmaceutical sector, dedicated to enhancing patient outcomes and overall quality of life with its groundbreaking neurological treatments.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $51.60 (+12.93%)
Market Cap
$2B
Free Cash Flow Yield
-3.61%
Beta (5Y)
0.90
Price Chart
Valuation
Market Cap$2B
P/B6.66
Profitability
EBITDA-$98M
EPS-$1.92
Financial Health
Free Cash Flow Yield-3.61%
Growth & Risk
Beta (5Y)0.90
Sharpe Ratio1.51